WHO approves first Mpox vaccine for limited use in select countries

The World Health Organization (WHO) has approved the MVA-BN vaccine, developed by Bavarian Nordic A/S, as the first vaccine for mpox. The vaccine has been added to the WHO’s prequalification list, aimed at improving access, particularly for communities in Africa facing urgent need. The two-dose vaccine has shown 82% effectiveness in preventing mpox after full administration. WHO Director-General Dr. Tedros Adhanom Ghebreyesus emphasized the importance of equitable access to the vaccine to curb ongoing outbreaks.

from IndiaTV World: Google News Feed https://ift.tt/YiZlsMr